6-(4-methoxyphenyl)hexan-1-ol | 102831-36-7

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 6-(4-methoxyphenyl)hexan-1-ol
• CAS: 102831-36-7
• 化学式: C₁₃H₂₀O₂
• 分子量: 208.301
• InChiKey: YGMHHBMWTJUUIM-UHFFFAOYSA-N

物化性质

• 沸点：
  334.8±25.0 °C(Predicted)
• 密度：
  0.992±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  15
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.54
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  6-(4-methoxyphenyl)hexan-1-ol 在 四溴化碳 、 三苯基膦 作用下， 生成 1-(6-溴己基)-4-甲氧基苯
  参考文献：
  名称：

  Materials chemistry of chiral macromolecules. 1. Synthesis and phase transitions

  摘要：

  This paper describes work on synthesis of chiral macromolecules as part of a materials chemistry study which seeks to establish links in these systems among molecular structure, three-dimensional molecular organization, and properties. The basic materials chemistry hypothesis driving this work is that chiral forces among stereogenic centers may serve as guiding fields to organize polymers in two or three dimensions. It follows that physical properties could be directly or indirectly controlled by chirality. In order to promote strong forces among chiral centers the chains were designed to have stereogenic carbons substituted by the strongly dipolar cyano group and spaced by 16 atoms along the backbone. The preparative chemistry of chiral macromolecules is challenging given the limited number of polymerization methodologies and the inherent translational periodicity of synthetic polymers. We have synthesized here low symmetry chiral macromolecules in which the only symmetry element retained is polar translation; achiral homologues lacking the nitrile function, the configurationally disordered polymer, and dimeric model compounds were prepared as well. The compounds exhibited crystalline and liquid crystalline phases, and significant differences were observed among homologues through differential scanning calorimetry and optical microscopy. The substitution of nitrile groups every 16 atoms along the polymer backbone, specially with configurational disorder, leads to glassy or less ordered condensed phases. In some Polymers when the strongly dipolar stereogenic centers do not have preferred handedness, chains organize into mesophases rather than crystalline structures. This is surprising since the concentration of stereogenic centers is extremely dilute. Using dimeric model compounds, homochiral recognition among stereogenic centers with large dipole moments was identified as an important factor in the assembly of molecules into layered structures. Interestingly, catenation of the dipolar stereogenic centers in polymeric compounds apparently leads to layered structures even when configurational disorder exists along the polymer backbone. This type of structural control could be extremely useful as an approach to tune physical properties of polymeric materials.

  DOI：

  10.1021/ja00035a041
• 作为产物：
  描述：

  6-(4-methoxyphenyl)hex-5-yn-1-ol 在 palladium on activated charcoal 甲酸 、 氢气 作用下， 以 乙醇 为溶剂， 反应 18.0h， 以100%的产率得到6-(4-methoxyphenyl)hexan-1-ol
  参考文献：
  名称：

  研究新型的浓度依赖性，双重作用的T型钙通道激动剂/拮抗剂的构效关系。

  摘要：

  本文描述了先前在我们的研究程序中合成的化合物（1）的一系列直链类似物的合成和生物学评估。这些化合物是T型钙通道拮抗剂，对多种癌细胞表现出有效的抗增殖活性。这些类似物与多种癌细胞的构效关系为深入研究该系列化合物的合理药效团提供了见解。此外，这一系列化合物已将自己呈现为一组针对T型钙通道的新型，浓度依赖性，双重作用的激动剂/拮抗剂。

  DOI：

  10.1016/j.bmc.2005.03.004

文献信息

• Nickel-Catalyzed Cross-Electrophile Coupling of Aryl Chlorides with Primary Alkyl Chlorides
  作者：Seoyoung Kim、Matthew J. Goldfogel、Michael M. Gilbert、Daniel J. Weix

  DOI：10.1021/jacs.0c02673

  日期：2020.6.3

  Alkyl chlorides and aryl chlorides are among the most abundant and stable carbon electrophiles. Although their coupling with carbon nucleophiles is well developed, the cross-electrophile coupling of aryl chlorides with alkyl chlorides has remained a challenge. We report here the first general approach to this transformation. The key to produc-tive, selective cross-coupling is the use of a small amount

  烷基氯和芳基氯是最丰富和最稳定的碳亲电子试剂。尽管它们与碳亲核试剂的偶联得到了很好的发展，但芳基氯化物与烷基氯化物的交叉亲电偶联仍然是一个挑战。我们在这里报告了这种转变的第一种一般方法。生产性、选择性交叉偶联的关键是使用少量碘化物或溴化物以及最近报道的配体吡啶-2,6-双(N-氰基甲脒) (PyBCamCN)。反应的范围用 35 个实例（平均产率为 63% ±16%）进行了证明，我们表明 Br- 和 I- 添加剂充当助催化剂，产生低、稳态浓度的更具反应性烷基溴/碘。
• GLYCOSIDE COMPOUND AND PREPARATION METHOD THEREFOR, COMPOSITION, APPLICATION, AND INTERMEDIATE
  申请人：SHANGHAI HUTCHISON PHARMACEUTICALS LIMITED

  公开号：US20210115082A1

  公开（公告）日：2021-04-22

  The present invention discloses a glycoside compound represented by Formula III, and a preparation method, a composition, use and an intermediate thereof. The glycoside compound provided in the present invention has simple preparation method, can significantly increase the expression of VEGF-A mRNA, and is effective in promoting the angiogenesis. This provides a reliable guarantee for the development of drugs with pro-angiogenic activity for treating cerebral infarction cerebral stroke, myocardial infarction, and ischemic microcirculatory disturbance of lower limbs.

  本发明公开了一种由III式表示的糖苷化合物，以及其制备方法、组合物、用途和中间体。本发明提供的糖苷化合物具有简单的制备方法，可以显著增加VEGF-A mRNA的表达，并且在促进血管生成方面具有有效性。这为开发具有促血管生成活性的药物治疗脑梗死、脑卒中、心肌梗死和下肢缺血微循环障碍提供了可靠的保证。
• Pyridine compounds for treating leukotriene-related diseases
  申请人：SmithKline Beecham Corporation

  公开号：US05631262A1

  公开（公告）日：1997-05-20

  ##STR1## This invention relates to compounds of formula (I) which are useful as leukotriene antagonists.

  这项发明涉及具有公式（I）的化合物，这些化合物可用作白三烯拮抗剂。
• 一种糖苷类化合物的制备方法
  申请人：上海和黄药业有限公司

  公开号：CN112625073B

  公开（公告）日：2022-01-18

  本发明涉及一种糖苷类化合物的制备方法，其合成工艺步骤短，产物构型单一，选择性高，收率高，生产操作简单，设备要求低，绿色环保适合工业大规模生产。
• Phenylalkan(en)oic acids
  申请人：ONO PHARMACEUTICAL CO., LTD.

  公开号：EP0405116A2

  公开（公告）日：1991-01-02

  The phenylalkan(en)oic acids of the formula: wherein the substituants are defined as in the disclosure, possess an antagonism on leukotriene B4, and therefore, are useful for the prevention and treatment of several diseases induced by leukotriene B4.

  式中的苯基烷(烯)酸： 其中的取代基定义与公开内容相同，具有拮抗白三烯 B4 的作用，因此可用于预防和治疗由白三烯 B4 引起的多种疾病。